US Stock MarketDetailed Quotes

DYAI Dyadic

Watchlist
  • 1.650
  • +0.020+1.23%
Trading Mar 28 09:34 ET
47.54MMarket Cap-7173P/E (TTM)

About Dyadic Company

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.

Company Profile

SymbolDYAI
Company NameDyadic
Listing Date04/17/2019
Founded1979
CEOMr. Mark A. Emalfarb
MarketNASDAQ
Employees11
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1044 North US Highway One,Suite 201
CityJupiter
ProvinceFlorida
CountryUnited States of America
Zip Code33477-5094
Phone1-561-743-8333

Company Executives

  • Name
  • Position
  • Salary
  • Mark A. Emalfarb
  • Director, President and Chief Executive Officer
  • 1.37M
  • Ping W. Rawson
  • Chief Financial Officer and Principal Accounting Officer
  • 541.28K
  • Joseph Hazelton
  • Chief Business Officer
  • 390.78K
  • Dr. Ronen Tchelet, PhD
  • Vice President of Research and Business Development
  • 305.84K
  • Michael P. Tarnok
  • Chairman of the Board
  • 219.98K
  • Jack L. Kaye
  • Independent Director
  • 219.98K
  • Patrick K. Lucy
  • Independent Director
  • 198.41K
  • Dr. Barry Buckland, PhD
  • Independent Director
  • 159.03K
  • Seth J. Herbst, M.D.
  • Independent Director
  • 159.03K
  • Arindam Bose, PhD
  • Independent Director
  • 219.98K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg